Knowledge graph · Drug
Pixantrone Dimaleate
small molecule
- Identifier
- CI-DRUG-00000792
- Entity page
- /drug/pixantrone-dimaleate ↗
- Edges
- 16
- Neighbours
- 10 cancers4 trials
- Drawn
- 14 of 14 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,149Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| Pixantrone Dimaleate approved for …APPROVED_FORderived1 of 1 | ||||||||
| → approved for | B-Cell Malignant Neoplasm EMA (EU) · withdrawn · 2012-05-10 · Pixuvri is indicated as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell … | — | withdrawn | B-Cell Malignant Neoplasm | 1 | Regulatory | ema | graph → |
| Pixantrone Dimaleate investigated for … | ||||||||